EUVIMEDEUVIMED entdecken
Crossref

Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19

Mohitosh Biswas

Archives of Immunology Research and Therapy · 2023

DOI: 10.58489/2836-5003/006 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Archives of Immunology Research and Therapy, 2023. Verfasst von Mohitosh Biswas.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

This study was aimed to investigate predictive prevalence of rs11385942 and rs657152 single nucleotide polymorphisms (SNPs) in the world populations since these were associated with severe COVID-19.

Methods

Genetic data of rs11385942 and rs657152 SNPs of the 26 populations were obtained from the 1000 Genomes project. Phenotypes were assigned as high-risk, medium-risk or no-risk based on the carrying of characteristics risk alleles.

Results

It was demonstrated that the prevalence of risk allele associated with rs11385942 SNP for developing severe COVID-19 was significantly different in various ethnic groups (Chi-square test, p

Zitieren

APA

Biswas, M. (2023). Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19. Archives of Immunology Research and Therapy. https://doi.org/10.58489/2836-5003/006

Vancouver

Biswas M. Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19. Archives of Immunology Research and Therapy. 2023. doi:10.58489/2836-5003/006

BibTeX
@article{Biswas2023,
  author = {Biswas, Mohitosh},
  title = {Prevalence of rs11385942 and rs657152 single nucleotide polymorphisms in the world population susceptible to severe COVID-19},
  journal = {Archives of Immunology Research and Therapy},
  year = {2023},
  doi = {10.58489/2836-5003/006}
}
Kostenlos starten →